The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Epirium Bio’s EB 002 ((+)-epicatechin) for the treatment of Duchenne and Becker muscular dystrophies. The designation supports the development of experimental treatments for rare diseases (those that affect fewer than 200,000 people in the…
Capricor Therapeutics will host a conference call and webcast with a cardiac expert to discuss heart complications associated with Duchenne muscular dystrophy (DMD) and will also provide an update on the development of CAP-1002, its lead cell therapy candidate for people with DMD. The event, at 1:30…
A CureDuchenne Ventures equity investment will support Dyne Therapeutics in developing precision treatments aimed at repairing muscles in Duchenne and other muscular dystrophies. The funding — whose amount was not disclosed — will help to advance the company’s efforts to target the genetic makeup of Duchenne muscular dystrophy (DMD), with a goal…
In the days when I still attended school, I was deemed an extrovert by my teachers and school officials. Never did I falter in putting myself “out there.” I was best known as the girl who won the talent show by belting out a Dixie Chicks song while…
Invitae and the Muscular Dystrophy Association (MDA) are partnering to expand access to free genetic testing and post-test counseling in the United States and Canada, with a goal of more quickly diagnosing muscular dystrophy. Testing is offered at no charge through Invitae’s Detect Muscular Dystrophy program, and is…
I’ve always sought silver linings, including in this season of social distancing. Many people now exclusively use technology to communicate with family, friends, and co-workers to reduce viral spread. Instead of hanging out at inaccessible places, people connect from the comfort of home. Self-quarantine has yielded plenty of valid complaints,…
First, the bad news: If you’re one of the 30 million or so Americans with a rare disease, you probably have lower immunity to the novel coronavirus than most people. Now, the good news: You already know how to face loneliness and adversity — qualities that make you far stronger…
The Muscular Dystrophy Association (MDA) is hosting an online Q&A session today to discuss the best ways that people with neuromuscular diseases might protect themselves during the COVID-19 pandemic. The 30-minute session can be accessed on the MDA’s Facebook page, and starts at 6 p.m. EST. People with…
Clinical trial data suggest that edasalonexent — a potential Duchenne muscular dystrophy (DMD) therapy — does not affect the immune system’s ability to work as it should, making it unlikely to raise a person’s COVID-19 risk, Catabasis Pharmaceuticals said. COVID-19 is believed to pose the greatest threat to older people and those…
Our Forums moderator Kevin Schaefer shared great advice for making the most out of your time while at home. To discuss, add more recommendations and leave your feedback please join the conversation in our Forums: click here. 1) Read: “Netflix and Hulu are great, but nothing gets your mind going…
Get regular updates to your inbox.